#nonacuity

[lietuvens]

kamer pasaule vai narkostikis mani nav apgriezis kajam gaisa man japiedzivo dienasgramatas rakstisanas eksistenciala krize lol ### divains vakars cakars satiku orr un tom orr tagad traki es pat nevaru iedomaties vai varbut varu pat iedomaties kaa tas ir.. // vina no izraelas\\\\ skiet ka varu izteloties kaa vina juutas un ta sajuta ir tik sausmigi auksta un attalinosa aaaaaaa _ prieks ar vinu laiku pavadit samilot skaut____ es vispar nesaprotu kaa es juutos es pedejas stundas dienas nedelas esmu pavadijusi divainos galvas mezglos bet kopsumma laikam ir labi tikai sausmigi daudz. svesums un majigums. jauni draugi nepamaniju pa kuru laiku kluva draugi par draugiem visp.|| tik savadi iet pa berlini ar cilvekiem kuru dzivesstastus isti es nezinu vai neatceros un man vini rup un vini tik specifiski un ipasi un forsi bet es joprojam nesaprotu kaa es te nonacu. skiet ka esmu talu prom no majam un draugiem un vakara tusiem bet taja pasa laika tiesi tas ir tas kas man apkart ir ::::: sajuta ka esmu kada svesa cilveka dzive ielekusi freaky friday typa shit. divaina diena. tuksa un pilna. klusa ar skalumu.

gaslight girlboss gatekeep

viss liekas bezmerkigs ari sis

kliedzu tuksuma sev pati pretim

bet interesanti tomer ir

[neelima0211]

Nanopore Technology Market Growth,Size | Forecast 2027

The global Nanopore Technology market size is expected to grow from US$ 250.5 Million in 2021 to US$ 490.2 Million by 2027, at a CAGR of 15.2% over the forecast period.

The Nanopore Technology Market report evaluates product market value, trends, regional market analysis, key players growth decision, the volume and value of the product, Information Analysis and future growth opportunity. The Nanopore Technology market report consists of trends that are anticipated to impact the growth of the Laparoscopic Hand Instrument market during the forecast period between 2022 and 2027. Evaluation of these trends is included in the report, along with their product innovations. This report also sheds light on the latest information on various specifications, buyer analysis, their purchasing decision, and price analysis, with deep insights on the leading suppliers.

Top Leading Companies of Nanopore Technology Market are – Cyclomics, Electronic Biosciences, Grandomics, INanoBio Inc, Qitan Technology, Quantapore, Inc., Nabsys, Inc., Nonacus, Inc., ONTERA, Inc., Oxford Nanopore Technologies, and others.

To Browse Full Report, Click the Link Below:

The report segments the global Nanopore Technology market as follows:

Global Nanopore Technology Market: By Type

Instruments

Consumables

Global Nanopore Technology Market: By Application

DNA Sequencing

RNA Sequencing

Global Nanopore Technology Market: By Region

The regional analysis highlights the strengths of each region along with, prominent companies and their growth potential, key issues and trends that face the regions, potential opportunities in the near future, and a discussion of how these regions potential overcome these challenges. The global Miticides market is divided into four regions: North America, Europe, Asia Pacific, and Latin America.

Inquire Before Buying Research Report:

Partnerships and acquisition to boost adoption and co-develop advanced solutions

The nanopore sequencing market has witnessed a number of partnerships and acquisition by market players to either enhance the adoption of this technology for clinical applications or to co-develop advanced sequencing platforms. Some of the strategic initiatives that boost the adoption of nanopore sequencing are listed below:

In April 2022, Oxford Nanopore Technologies collaborated with Genomics England to evaluate the benefits of sequencing for enhancing patient care and advancing research activities for the development of novel treatments on a larger scale using nanopore sequencing technology

In September 2021, Oxford Nanopore Technologies collaborated with Oracle to explore novel applications of genomic sequencing using the Oracle Cloud Infrastructure (OCI) to speed-up discovery of medical innovations

In August 2020, Oxford Nanopore Technologies entered into an agreement with the UK’s Department of Health and Social Care, to roll out its LamPORE SARS-CoV-2 tests at a number of NHS testing laboratories

In May 2020, F. Hoffmann-La Roche Ltd acquired Stratos Genomics, a US based fourth-generation genetic sequencing company, to advance the development of nanopore sequencer for diagnostic applications with the combination of electronics and biological components

Report Highlights:

Detailed analysis of Nanopore Technology market dynamics, including market drivers, restraints and opportunities

Detailed analysis of the market segments, including technology, application, end-user and region

A comprehensive analysis of the Nanopore Technology competitive landscape, including market share and company profiles of the key players

Value chain analysis of the key players in the Nanopore Technology market

Analysis of the micro and macro-economic indicators that affect the market

About Industry Data Analytics : Industry Data Analytics provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.

Industry Data Analytics provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us: Irfan Tamboli (Head of Sales) – Industry Data Analytics Phone: + 1704 266 3234 | +91-750-707-8687 sales@marketinsightsreports.com | irfan@marketinsightsreports.com

[scholarship45]

Urine test for bladder cancer: What is the latest urine test?

Urine test for bladder cancer: What is the latest urine test?

Back in July last year, we announced that the University of Birmingham had partnered with Nonacus, Provider of genetic testing products for precision medicine and liquid biopsyto produce a urine test for bladder cancer. Now, less than a year later, the first results from the partnership are out. The test will use highly sensitive liquid biopsy technology developed by Nonacus in conjunction with a…

[11hoursstarsatnightblack]

Kas attiecas uz konfliktu, kas mums radaas jauno gadu iesakot- es par to loti pardzivoju, jutos pievilta taja draudzibas telpa starp mums, kura vairs nejutu siltumu, domaju daudz, bet nevareju atrast istos vardus un saprast vai man vispar par to jadalas ar tevi. Es uzzimeju taro kolazhas taja diena.

Bet es biju bediga par so visu musu starpa pat nakamaja diena un jutu, ka mani pat parnemis kaut kads tavs makonis un es to jau saku starot talak citiem cilvekiem 😤

Tad es saku domat kapec vispar par to taa pardzivoju. Un tad es laikam nonacu pie atbildes par so konfliktu, kas attiecas uz mani. Domaju ar to padalities, jo varbut tev ir tas pats - tikai no tavas puses:)

>>> But apzinatakai par savam robezam un sekot, palauties taam. Robezas tiesi dara brivaku un stipraku.

Man skiet, ka starp mums vai drizak ar mums , kad esam kopa = magicks, bet tas var ari but tikai potencials un musu pasu izvele to pilnveidot jeb to Apzinaties.

Ja tu tam neesi gatava , tad tas nav mans uzdevums ieslegt gaismu jeb pareizak sakot - atvert logus tavaa makonii. Man nav jaaiemaacaas kaa ar tevi apieties un tev nav jaaiemaacas, kaa mani neaizskart ar savu depresso aizkaitinajumu, ja tevi tas neruup.

Mans vienigais uzdevums ir pasargat sevi, lai caur savu empatiju ( kura ar tevi ir vel xx reizes speeciigaaka manaa jau taa over empathetic universe) nepaarnjemu to sevii. Biezi tas varbut nozime tiesam ieturet distanci ( emocionalu) .

Pff smiekligi so rakstit, jo zinu, ka daziem cilvekiem taa ir ar mani. Piemeram, manai manmai.

Tur vel viens prikols, kaa piedzivoju saskarsmi ar tevi - taads empaatij-spoguljatteels, bet ar kkadu citu laiktelpu. Laika nobiidi.

Kad tev ir slikti, tad esi parnjemta ar savam emocijam un neviens cits, arpasaule vairs neeksiste, lidz ar to ari zuud robeza un viss, kas censas par to atgadinat= drauds, tadel Reage ar aizkaitinajumu/ attaisnosanos/ dusmam. Tas ir egoistiski un es nenemu savus vardus atpakal. Ceru tikai, ka esi aware of that. Tad jau viss ir taa, kaa veelies un man nav tiesibas egoismu izteikt kaa paarmetumu. man tikai jadoma, kaa lai sevi neietekmeju jeb vienkarsi neesmu tev klat, kad taa notiek.

Tu taapat esi mana gimene un maasa, kad un ja vien velies. Sis viss process un vai mums ir konflikti, magicks vai nee- tas to nemaina. Es taapat vienmer esmu par tevi.

Bet jaatceras, it is what WE make it to be.

___Releasing the barriers between you and you ____

Tiesi apzinoties savas Robezas

Un vairak stiprinot simply loving kindnes & compassion empathy ( metta) vienalga pret sevi vai citiem = exit from ur own gray cloud bubble

Tiesi mirklos kad juties vissudigak- padomat par kaadu, kuram veeli labu un sajust to loving kindness var novirzit un izvirzit sevi aaraa no makonja

[otwolintl-blog]

Review 9.1.16 episode 4 #timymeetbasti #reposting @lavie252525 @nonacu #tillimetyou #jadine💜 #jamesreid #nadinelustre

[bharatiyamedia-blog]

Noninvasive prenatal prognosis for fetal sickle cell illness strikes a step nearer

http://tinyurl.com/y23e5kk9 Sickle cell illness (SCD) is a type of anaemia that’s inherited when each mother and father are carriers of a mutation within the haemoglobin gene. At the moment, it will possibly solely be recognized in being pregnant by finishing up an invasive take a look at that has a small danger of miscarriage and is due to this fact typically declined by mother and father. Now, researchers from Man’s and St Thomas’ NHS Basis Belief and Viapath Analytics, London, UK, in collaboration with non-invasive healthcare firm Nonacus Ltd., Birmingham, UK, have developed a non-invasive prenatal take a look at for the illness, the annual convention of the European Society of Human Genetics will hear tomorrow (Sunday). Dr Julia van Campen, analysis scientist at Man’s and St Thomas’, explains: « Now we have developed a way of testing for SCD utilizing cell-free fetal DNA – DNA from the fetus that circulates within the maternal bloodstream. Though cell-free fetal DNA testing is already out there for some issues, technical difficulties have hampered the event of such a take a look at for SCD, regardless of it being one of the generally requested prenatal checks within the UK. » In {couples} who’re prone to having a child with SCD, every associate carries a mutation within the haemoglobin gene, which signifies that any fetus has a one in 4 likelihood of inheriting each mutations and due to this fact being affected by SCD. Non-invasive prenatal prognosis (NIPD) of situations which can be inherited on this manner is tough. “The event of a non-invasive prenatal assay for sickle cell illness has been tried earlier than and, till now, has not been profitable,”says Dr van Campen. The researchers analysed samples from 24 pregnant SCD carriers. Utilizing distinctive molecular identifiers, a form of molecular barcode, they had been in a position to scale back errors, and by solely analysing smaller fragments they had been in a position to improve the fetal contribution to the samples. This led to profitable prognosis of the sickle cell standing for 21 of the 24 pregnancies, in samples from as early as eight weeks gestation, with three samples giving inconclusive outcomes. Additional growth and validation of the findings is ongoing. Worldwide, there are over 300 0001 youngsters born with SCD annually. It’s the most typical genetic haematological dysfunction, with hundreds of thousands of individuals at the moment affected throughout the globe. There are about 14 000 individuals residing with SCD within the UK, or one in 4600. Roughly 560 {couples} prone to passing on the illness per 12 months are detected by the nationwide antenatal screening programme, which gives service testing to pregnant ladies and if acceptable their companions. Prenatal prognosis is accessible to those {couples} to check whether or not the fetus has SCD. Earlier analysis has proven that if the choice of a non-invasive take a look at had been out there, extra ladies whose fetus is prone to sickle cell illness would go for prenatal testing 2. « Nevertheless, many {couples} are unaware that they’re in danger till being pregnant happens, although service testing and follow-up genetic counselling is accessible by the UK Nationwide Well being Service for many who are involved that they might carry SCD, » says Dr van Campen. « You will need to elevate consciousness of SCD, which at the moment is restricted. » Analysis is ongoing, and earlier than the assay will be launched into medical follow it must be examined additional to ensure that it performs properly sufficient for use as a diagnostic take a look at. « We additionally must work to make sure that it will possibly present outcomes quickly sufficient to provide ladies solutions on the proper time of their being pregnant, and that it may be carried out at a value that healthcare suppliers can afford. I’m excited that this work has given higher outcomes than I had anticipated, and am hopeful that folks will be capable of construct on this work to make this take a look at out there within the close to future,” » Dr van Campen will conclude. Chair of the ESHG convention, Professor Joris Veltman, Director of the Institute of Genetic Medication at Newcastle College, Newcastle upon Tyne, UK, mentioned: “The event of non-invasive genetic checks that may be safely used throughout being pregnant is essential to determine fetuses with extreme issues. These scientists have developed a novel state-of-the artwork genomics strategy to do that for sickle cell illness in {couples} in danger. Their first outcomes offered on the ESHG convention point out that their take a look at may be very promising.” ### 1Piel et al. International Burden of Sickle Cell Anaemia in Kids beneath 5, 2010-2050: Modelling Based mostly on Demographics, Extra Mortality, and Interventions https://doi.org/10.1371/journal.pmed.1001484 2Hill, M., Oteng-Ntim, E., Forya, F., Petrou, M., Morris, S., & Chitty, L. S. (2017). Preferences for prenatal prognosis of sickle-cell dysfunction: A discrete selection experiment evaluating potential service customers and health-care suppliers., Well being expectations: a global journal of public participation in well being care and well being coverage, 20(6), 1289-1295 Summary no: C08.5 Non-invasive prenatal prognosis of sickle cell illness by subsequent technology sequencing of cell-free DNA Disclaimer: AAAS and EurekAlert! should not liable for the accuracy of reports releases posted to EurekAlert! by contributing establishments or for the usage of any info by the EurekAlert system. Source link

[otwolintl-blog]

TB #TIMY review 10.24.16 episode 41 #timytheproposal #repost @nonacu #jadine💜 #jamesreid #nadzlustre

[otwolintl-blog]

Loving our JaDine fanMily....until we meet again! 💓🙏🏽 #repost @lavie252525: Vienna, the city of culture.. This is Schönnbrunn the Versailles of Austria. We had so much fun, giggles and laughter right in this place. We attempted for a jump shot but it turned into an epic fail.. Me and my Jadine sisters @nonacu @loryjoy76 .. Grateful for these lovely women!! A successful travel depends who you're with.. I found new great travel buddies and the best part is we can chat all day long about JADINE!! What bliss!! 😙😙😙😙😙 @otwol_international (at London, United Kingdom)

[otwolintl-blog]

#repost @lavie252525: Finally, with my Jadine sisters!! @loryjoy76 Thank you for the winter hats @nonacu #teamreal #jadine💜 #jadine @otwol_international (at Vienna, Austria)